Literature DB >> 27152041

Image-guided stereotactic radiotherapy in 4 dogs with intracranial neoplasia.

Alaina Burkard Moon1, Heidi Barnes Heller1, Lisa Forrest1.   

Abstract

The purpose of this study was to describe the use, and side effects, of a novel stereotactic radiotherapy protocol using TomoTherapy(®) in 4 dogs with confirmed or suspected primary extra-axial intracranial neoplasia. Three fractions of 8 Gy were prescribed. Acute side effects were noted in 1 dog; no late effects were noted.

Entities:  

Mesh：

Year:  2016        PMID： 27152041      PMCID： PMC4827744     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  12 in total

1.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

Review 2.  Conformity index: a review.

Authors:  Loïc Feuvret; Georges Noël; Jean-Jacques Mazeron; Pierre Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-01       Impact factor: 7.038

3.  Radiosurgery using a stereotactic headframe system for irradiation of brain tumors in dogs.

Authors:  N V Lester; A L Hopkins; F J Bova; W A Friedman; J M Buatti; S L Meeks; C L Chrisman
Journal:  J Am Vet Med Assoc       Date:  2001-12-01       Impact factor: 1.936

4.  Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.

Authors:  C L Mariani; T A Schubert; R A House; M A Wong; A L Hopkins; H L Barnes Heller; R J Milner; N V Lester; D M Lurie; D A Rajon; W A Friedman; F J Bova
Journal:  Vet Comp Oncol       Date:  2013-09-06       Impact factor: 2.613

5.  Stereotactic radiosurgery and fracture fixation in 6 dogs with appendicular osteosarcoma.

Authors:  Jennifer L Covey; James P Farese; Nicholas J Bacon; Sandra P Schallberger; Pierre Amsellem; Ryan P Cavanaugh; Rowan J Milner
Journal:  Vet Surg       Date:  2014-01-06       Impact factor: 1.495

6.  Stereotactic radiation therapy for treatment of canine intracranial meningiomas.

Authors:  L R Griffin; M W Nolan; L E Selmic; E Randall; J Custis; S LaRue
Journal:  Vet Comp Oncol       Date:  2014-12-18       Impact factor: 2.613

7.  Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs.

Authors:  James P Farese; Rowan Milner; Margaret S Thompson; Nola Lester; Kirsten Cooke; Leslie Fox; Juli Hester; Francis J Bova
Journal:  J Am Vet Med Assoc       Date:  2004-11-15       Impact factor: 1.936

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.

Authors:  Emilie T Soisson; Wolfgang A Tomé; Gregory M Richards; Minesh P Mehta
Journal:  Radiother Oncol       Date:  2006-02-20       Impact factor: 6.280

10.  Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours.

Authors:  Sergio Ródenas; Marti Pumarola; Lluís Gaitero; Angels Zamora; Sònia Añor
Journal:  Vet J       Date:  2009-11-14       Impact factor: 2.688
View more
  1 in total

1.  Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).

Authors:  M Debreuque; P De Fornel; I David; F Delisle; M N Ducerveau; P Devauchelle; J L Thibaud
Journal:  BMC Vet Res       Date:  2020-10-31       Impact factor: 2.741
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.